Optibiotix Health Share Discussion Threads

[john henry] 04/10/2017 09:41

Shazbo, As I've pointed out to S OHara on a few occasions the companies share registrar is very very light on institutional investment and the institution that does hold is slowly selling down. PI hold the majority of stock here and over the past two years has very much developed into a trading stock. Hence you get this continued up 10% down 10% the price never holds because the buyers aren't buying to hold. I guess institutional investors will appear when there is earnings visibility until then OPTI will be at the mercy of the traders.

[semper vigilans] 04/10/2017 09:39

Agree RAF - attitudes differ between here and the US where companies have obviously silly ratings.
Happier with the conservative attitude here, but the IP of this and other companies does have some value.
However, the big boys like to add to their empires with huge add-ons rather than take a punt on smaller stuff which would give better returns but with proportionately more work.

[fathenry] 04/10/2017 09:39

mate simple question or do you like wat yiu are seein, down and diwn

[shazbo] 04/10/2017 09:13

someuwin, can't you ban this moron?

[fathenry] 04/10/2017 09:04

wat rimes with yuk dont this ever go up

[rafboy] 04/10/2017 08:23

Trouble is we have had a long stream of positive updates but no real visibility of revenue and income. I now think the market wants to see real income before it fully takes the plunge. Of course we are fortunate having recognised the potential in OPTI from an early stage.

[john henry] 04/10/2017 08:15

Very good update, it's a shame that presently, its an opinion that is only shared on here.

[owenmo] 04/10/2017 07:56

I agree Trotters, another cracking RNS. Sorry for typo in opening sentence of earlier post; my drift will be clear enough.

[trotterstrading] 04/10/2017 07:56

Underestimating SoH will cost some people their early retirement

[jestercat2] 04/10/2017 07:56

That's a great RNS - the extension in product range is very significant - looks like you can put the stuff into virtually any food product - including salad!

[owenmo] 04/10/2017 07:52

If this share was the buy of the "buy of the decade" s year ago, with finzncisl commitment and personnel now in place in Asia and in USA to take science to commercial success, Opti, at current share price is the steal of the Century. Yes we have no revenue projections; when we do, share price will paint a very different picture. call it ramping if you will; see if I care. Of course I share frustrations at lack of market response; our day, whatever about our kingdom, will come.

[colinzeal] 04/10/2017 07:48

I was referring to the recent share price weakness rather than the long term range we've been in. But well done if you've made a few quid your honour!

[trotterstrading] 04/10/2017 07:47

Another cracking RNS, no comments so far this morning tells me the BB has a bit of 'good news' fatigue. Sacco's product manager appointment is significant and underlines their commitment and expectations for LP-LDL. Also the huge expansion in product range for Slimbiome opens up massive revenue stream potential. I'm beginning to understand why a highly successful businesswomen like Christina joined to become Slimbiome sales director

[someuwin] 04/10/2017 07:06

04 October 2017




OptiBiotix Health plc

("OptiBiotix" or the "Company")



Successful launch of LPLDL® and SlimBiome® products at Supply Side West 2017



OptiBiotix Health plc (AIM:OPTI), a life sciences business developing compounds to tackle obesity,high cholesterol, and diabetes announces the successful launch of its SlimBiome® and LPLDL® products at Supply Side West in Las Vegas, on 27-28 September 2017. The exhibition provided the opportunity to connect with 16,500 ingredient buyers and suppliers from the supplement, beverage, functional food, personal care and sports nutrition industries. The event also created the opportunity to meet with senior executives from existing corporate partners and potential new corporate partners, as well as distributors from Europe, the USA and Asia.



The Company recently obtained FDA registration for both its LPLDL® and SlimBiome® product ranges allowing it to present its products at Supply Side West as the first of a number of commercial steps to supply these functional ingredients to food, beverage, consumer healthcare and pharmaceutical partners for distribution and sale into the US market. LPLDL® was co-exhibited with Sacco, one of the largest suppliers of probiotic ingredients, whilst SlimBiome® was co-exhibited with specialty ingredients manufacturer, Cereal Ingredients.



Both LPLDL® and SlimBiome® were extremely well received with high interest in the distribution and sale of these products from partners across Europe, Japan, India, Asia and the USA. Further updates will be provided as interest develops into commercial agreements but early outcomes from the exhibition include:-



1. Sacco have appointed Dr Lucio Lepera as Product Manager for LPLDL®. This is a significant financial commitment from Sacco, to support entry to the US probiotic market and extend the opportunities offered by LPLDL® into dairy applications to access the $35.5 billion probiotic dairy market.



2. Cereal Ingredients have incorporated SlimBiome® into their range of cereal based particulates and speciality ingredients. This technical innovation extends the application of SlimBiome® into bakery products (e.g. cookies, cakes and tortillas), breakfast cereals (puffs and flakes), crackers, toppings (e.g. salad, breakfast) as well as increasing the range of options for healthy snacks, yoghurts and cereal bars. This significantly extends the scale of the opportunity beyond weight management into the nutraceutical, health and wellbeing industry sectors.





Stephen O'Hara, CEO of OptiBiotix, commented: "We are extremely pleased with the very high level of interest from both national and multinational companies interested in our products and the opportunity to meet with senior US and Asian decision makers at Supply Side West. We are particularly pleased by the commitment shown by our partners who have invested significant financial resources in providing exhibition space, appointed and trained new personnel, and developed new products at their own cost, to support the commercialisation of our products. We believe this reflects the high level of confidence in the commercial potential of our products. As we build the range of applications and geographic scope of LPLDL® and SlimBiome® with new manufacturing and distribution partners; the scale of the opportunity enlarges allowing us to fully exploit the revenue generating potential of our products. If successful, this low risk, low cost approach to accessing multiple consumer healthcare and pharmaceutical markets around the world with multiple products has the potential to cumulatively generate substantive revenues in the forthcoming years across all platforms."

[ironman22] 03/10/2017 23:51

Colinzeal. Not nervous PI's hovering over the sell button as you put it but experienced investors who know the pattern and have watched this stock rise and fall like clockwork over the past 18 months to two years and who will have no doubt made a lot more money then any 'LTH's'.

[europa79] 03/10/2017 20:44

Wish I'd waited a little bit longer before topping up,....typical aim.
Untypical stock!!

[vanduke] 03/10/2017 19:34

Off topic:Yu. We have been buying

[bobdown2] 03/10/2017 19:18

Very suprised that the drop today was not bought into considering everything that is happening at the moment.. I would imagine we might see a graph that explains why...

[elrico] 03/10/2017 18:18

Unless there is a late reported sell, this must be the largest drop on what must be the smallest volume I can remember. If that is not a MM red flag I have no idea what is.

[elrico] 03/10/2017 18:15

More filter fodder - fathenry3 Oct '17 (Filtered)

[2350220] 03/10/2017 16:37

Oh look, a member for one whole day, and that's the best post you can come up with??
You're what the filter button is made for.
John